Ran Frenkel - EVP, Karyopharm Therapeutics Inc

As of March 1, 2021


Ran Frenkel Net Worth

  • Net worth is estimated to be at least $448.11K
  • Owns at least 46,126 units of Karyopharm Therapeutics Inc stock
  • Sold an estimated value of $252.12K in the last 7 years at Karyopharm Therapeutics Inc

Ran Frenkel Trading

  • Largest purchase of shares was 3,000 units , worth over $95.43K on April 8, 2015
  • Largest sale of shares was 4,958 units , worth over $55.76K on November 9, 2017
  • In total has made about 19 transactions over 7 years
  • Usually trades in February, with the busiest year in 2020 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Ran Frenkel Mailing Address

  • Mailing address is C/o Karyopharm Therapeutics Inc. 85 Wells Avenue, 2nd Floor Newton MA 02459 MA

Karyopharm Therapeutics Inc Insider Trading

  • The most recent transaction was 499 units sold on December 3, 2021 by Stephen Mitchener worth over $3.34K
  • In the last 8 years, insiders at Karyopharm Therapeutics Inc sold an estimated value of $143.15M and bought an estimated value of $33.43M
  • The most active traders are Michael Kauffman, Chief Executive Officer,  Sharon Shacham, President & CSO,  and Andreas Hadjimichael
  • Insider trading is most common in February, with the busiest year in 2018

Karyopharm Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1